INFUSYSTEM HOLDINGS INC (INFU) Fundamental Analysis & Valuation

NYSEARCA:INFU • US45685K1025

Current stock price

10.37 USD
+0.24 (+2.37%)
At close:
10.37 USD
0 (0%)
After Hours:

This INFU fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. INFU Profitability Analysis

1.1 Basic Checks

  • In the past year INFU was profitable.
  • In the past year INFU had a positive cash flow from operations.
  • In the past 5 years INFU has always been profitable.
  • Each year in the past 5 years INFU had a positive operating cash flow.
INFU Yearly Net Income VS EBIT VS OCF VS FCFINFU Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M -20M

1.2 Ratios

  • With an excellent Return On Assets value of 6.59%, INFU belongs to the best of the industry, outperforming 84.16% of the companies in the same industry.
  • With a decent Return On Equity value of 11.56%, INFU is doing good in the industry, outperforming 76.24% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 11.72%, INFU belongs to the top of the industry, outperforming 85.15% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for INFU is in line with the industry average of 8.40%.
  • The 3 year average ROIC (7.25%) for INFU is below the current ROIC(11.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 6.59%
ROE 11.56%
ROIC 11.72%
ROA(3y)3.23%
ROA(5y)2.23%
ROE(3y)5.77%
ROE(5y)4.06%
ROIC(3y)7.25%
ROIC(5y)5.18%
INFU Yearly ROA, ROE, ROICINFU Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 -40 -60

1.3 Margins

  • INFU's Profit Margin of 4.62% is fine compared to the rest of the industry. INFU outperforms 76.24% of its industry peers.
  • INFU's Profit Margin has declined in the last couple of years.
  • The Operating Margin of INFU (8.31%) is better than 75.25% of its industry peers.
  • INFU's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 55.98%, INFU belongs to the top of the industry, outperforming 80.20% of the companies in the same industry.
  • INFU's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 8.31%
PM (TTM) 4.62%
GM 55.98%
OM growth 3Y76.76%
OM growth 5Y-1.72%
PM growth 3Y555.86%
PM growth 5Y-23.64%
GM growth 3Y-0.56%
GM growth 5Y-1.49%
INFU Yearly Profit, Operating, Gross MarginsINFU Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. INFU Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), INFU is creating some value.
  • INFU has less shares outstanding than it did 1 year ago.
  • INFU has less shares outstanding than it did 5 years ago.
  • INFU has a better debt/assets ratio than last year.
INFU Yearly Shares OutstandingINFU Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5M 10M 15M 20M
INFU Yearly Total Debt VS Total AssetsINFU Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

  • INFU has an Altman-Z score of 4.07. This indicates that INFU is financially healthy and has little risk of bankruptcy at the moment.
  • INFU has a better Altman-Z score (4.07) than 79.21% of its industry peers.
  • The Debt to FCF ratio of INFU is 1.25, which is an excellent value as it means it would take INFU, only 1.25 years of fcf income to pay off all of its debts.
  • INFU's Debt to FCF ratio of 1.25 is amongst the best of the industry. INFU outperforms 84.16% of its industry peers.
  • INFU has a Debt/Equity ratio of 0.34. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of INFU (0.34) is better than 65.35% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.25
Altman-Z 4.07
ROIC/WACC1.32
WACC8.86%
INFU Yearly LT Debt VS Equity VS FCFINFU Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M 40M

2.3 Liquidity

  • INFU has a Current Ratio of 1.80. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
  • INFU's Current ratio of 1.80 is fine compared to the rest of the industry. INFU outperforms 72.28% of its industry peers.
  • INFU has a Quick Ratio of 1.53. This is a normal value and indicates that INFU is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.53, INFU is in the better half of the industry, outperforming 63.37% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.8
Quick Ratio 1.53
INFU Yearly Current Assets VS Current LiabilitesINFU Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

6

3. INFU Growth Analysis

3.1 Past

  • INFU shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 220.00%, which is quite impressive.
  • INFU shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -17.01% yearly.
  • INFU shows a small growth in Revenue. In the last year, the Revenue has grown by 6.36%.
  • INFU shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.05% yearly.
EPS 1Y (TTM)220%
EPS 3Y632.25%
EPS 5Y-17.01%
EPS Q2Q%150%
Revenue 1Y (TTM)6.36%
Revenue growth 3Y9.28%
Revenue growth 5Y8.05%
Sales Q2Q%7.04%

3.2 Future

  • The Earnings Per Share is expected to grow by 28.50% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, INFU will show a small growth in Revenue. The Revenue will grow by 7.39% on average per year.
EPS Next Y32.54%
EPS Next 2Y28.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.87%
Revenue Next 2Y4.04%
Revenue Next 3Y6.65%
Revenue Next 5Y7.39%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
INFU Yearly Revenue VS EstimatesINFU Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M 200M
INFU Yearly EPS VS EstimatesINFU Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.1 0.2 0.3 0.4 0.5

More info and screens

Find the best growth stocksShow best growing peers

4

4. INFU Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 32.41 indicates a quite expensive valuation of INFU.
  • The rest of the industry has a similar Price/Earnings ratio as INFU.
  • When comparing the Price/Earnings ratio of INFU to the average of the S&P500 Index (26.64), we can say INFU is valued slightly more expensively.
  • The Price/Forward Earnings ratio is 24.45, which indicates a rather expensive current valuation of INFU.
  • INFU's Price/Forward Earnings ratio is in line with the industry average.
  • The average S&P500 Price/Forward Earnings ratio is at 21.36. INFU is around the same levels.
Industry RankSector Rank
PE 32.41
Fwd PE 24.45
INFU Price Earnings VS Forward Price EarningsINFU Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of INFU indicates a somewhat cheap valuation: INFU is cheaper than 77.23% of the companies listed in the same industry.
  • Based on the Price/Free Cash Flow ratio, INFU is valued a bit cheaper than the industry average as 76.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 13.32
EV/EBITDA 8.96
INFU Per share dataINFU EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • INFU has a very decent profitability rating, which may justify a higher PE ratio.
  • INFU's earnings are expected to grow with 28.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)1
PEG (5Y)N/A
EPS Next 2Y28.5%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. INFU Dividend Analysis

5.1 Amount

  • No dividends for INFU!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

INFU Fundamentals: All Metrics, Ratios and Statistics

INFUSYSTEM HOLDINGS INC

NYSEARCA:INFU (5/1/2026, 8:04:00 PM)

After market: 10.37 0 (0%)

10.37

+0.24 (+2.37%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Industry Strength49.07
Industry Growth86.96
Earnings (Last)02-24
Earnings (Next)05-07
Inst Owners81.24%
Inst Owner Change0.86%
Ins Owners4.84%
Ins Owner Change0.02%
Market Cap209.37M
Revenue(TTM)143.44M
Net Income(TTM)6.63M
Analysts83.64
Price Target15.2 (46.58%)
Short Float %1.13%
Short Ratio1.95
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)35.11%
Min EPS beat(2)34.8%
Max EPS beat(2)35.41%
EPS beat(4)4
Avg EPS beat(4)93.13%
Min EPS beat(4)34.8%
Max EPS beat(4)226.8%
EPS beat(8)5
Avg EPS beat(8)-2.06%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.98%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-2.81%
Revenue beat(4)1
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.99%
Revenue beat(8)2
Avg Revenue beat(8)-1.79%
Revenue beat(12)6
Avg Revenue beat(12)0.11%
Revenue beat(16)7
Avg Revenue beat(16)-0.97%
PT rev (1m)0%
PT rev (3m)4.93%
EPS NQ rev (1m)0%
EPS NQ rev (3m)28.46%
EPS NY rev (1m)0%
EPS NY rev (3m)1.12%
Revenue NQ rev (1m)0.59%
Revenue NQ rev (3m)-0.6%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.98%
Valuation
Industry RankSector Rank
PE 32.41
Fwd PE 24.45
P/S 1.46
P/FCF 13.32
P/OCF 8.58
P/B 3.65
P/tB 4.48
EV/EBITDA 8.96
EPS(TTM)0.32
EY3.09%
EPS(NY)0.42
Fwd EY4.09%
FCF(TTM)0.78
FCFY7.51%
OCF(TTM)1.21
OCFY11.66%
SpS7.1
BVpS2.84
TBVpS2.32
PEG (NY)1
PEG (5Y)N/A
Graham Number4.52141 (-56.4%)
Profitability
Industry RankSector Rank
ROA 6.59%
ROE 11.56%
ROCE 14.83%
ROIC 11.72%
ROICexc 12.2%
ROICexgc 14.14%
OM 8.31%
PM (TTM) 4.62%
GM 55.98%
FCFM 10.96%
ROA(3y)3.23%
ROA(5y)2.23%
ROE(3y)5.77%
ROE(5y)4.06%
ROIC(3y)7.25%
ROIC(5y)5.18%
ROICexc(3y)7.43%
ROICexc(5y)5.29%
ROICexgc(3y)8.54%
ROICexgc(5y)6.12%
ROCE(3y)9.18%
ROCE(5y)6.56%
ROICexgc growth 3Y98.79%
ROICexgc growth 5Y1.51%
ROICexc growth 3Y99.27%
ROICexc growth 5Y2.4%
OM growth 3Y76.76%
OM growth 5Y-1.72%
PM growth 3Y555.86%
PM growth 5Y-23.64%
GM growth 3Y-0.56%
GM growth 5Y-1.49%
F-Score8
Asset Turnover1.43
Health
Industry RankSector Rank
Debt/Equity 0.34
Debt/FCF 1.25
Debt/EBITDA 0.78
Cap/Depr 65.34%
Cap/Sales 6.06%
Interest Coverage 9.59
Cash Conversion 96.8%
Profit Quality 237.24%
Current Ratio 1.8
Quick Ratio 1.53
Altman-Z 4.07
F-Score8
WACC8.86%
ROIC/WACC1.32
Cap/Depr(3y)98.96%
Cap/Depr(5y)104.73%
Cap/Sales(3y)9.37%
Cap/Sales(5y)11.62%
Profit Quality(3y)120.46%
Profit Quality(5y)2807.88%
High Growth Momentum
Growth
EPS 1Y (TTM)220%
EPS 3Y632.25%
EPS 5Y-17.01%
EPS Q2Q%150%
EPS Next Y32.54%
EPS Next 2Y28.5%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.36%
Revenue growth 3Y9.28%
Revenue growth 5Y8.05%
Sales Q2Q%7.04%
Revenue Next Year0.87%
Revenue Next 2Y4.04%
Revenue Next 3Y6.65%
Revenue Next 5Y7.39%
EBIT growth 1Y72.98%
EBIT growth 3Y93.16%
EBIT growth 5Y6.19%
EBIT Next Year201.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y498.71%
FCF growth 3Y86.06%
FCF growth 5Y36.11%
OCF growth 1Y19.3%
OCF growth 3Y11.69%
OCF growth 5Y3.78%

INFUSYSTEM HOLDINGS INC / INFU Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for INFUSYSTEM HOLDINGS INC?

ChartMill assigns a fundamental rating of 6 / 10 to INFU.


What is the valuation status for INFU stock?

ChartMill assigns a valuation rating of 4 / 10 to INFUSYSTEM HOLDINGS INC (INFU). This can be considered as Fairly Valued.


Can you provide the profitability details for INFUSYSTEM HOLDINGS INC?

INFUSYSTEM HOLDINGS INC (INFU) has a profitability rating of 7 / 10.


How financially healthy is INFUSYSTEM HOLDINGS INC?

The financial health rating of INFUSYSTEM HOLDINGS INC (INFU) is 8 / 10.